$GCTS DD: Strong FWA/NTN Potential, but Can It Finally Turn Technical Progress into Revenue?

I'm a retail investor from South Korea. Looking back, I obviously wish I had taken some profits when the stock hit $4. But I still believe in the company's potential, and I'm holding through the upcoming Q3 and Q4 earnings. **My investment thesis comes down to three things: (1) growing chip shipments in the FWA/CPE market, (2) commercialization with the unnamed satellite operator, and (3) potential TAM expansion into new edge devices such as robotics and smart glasses.** # 1. FWA/CPE — The Most Realistic Near-Term Growth Driver The outlook for the FWA market remains quite positive. Ericsson projects global FWA connections to grow from 185 million in 2025 to 350 million by 2031. Dell'Oro also expects annual spending on FWA infrastructure and CPE to remain above $10 billion through 2029. GCTS has already built references involving Verizon, Orbic, and Airspan, along with its collaboration with MaxLinear. One interesting development is Inseego's recent acquisition of Nokia's FWA CPE business. Jeff Tuder, Chairman of Inseego's Board, also serves on GCTS's Board of Directors. Of course, this doesn't establish a direct supply relationship between the two companies, but it's an interesting connection to keep an eye on as the FWA industry evolves. # 2. NTN — The Biggest Potential Upside During the March earnings call, GCTS's CEO discussed potential annual demand of over 1 million units from its unnamed global satellite customer, describing that figure as the low end of expected annual volumes. Management has also previously mentioned an average ASP of approximately $40 for its 5G chips. At 1 million units, that would imply roughly $40 million in potential annual revenue, assuming a similar ASP. That's a meaningful opportunity relative to GCTS's current revenue base. Of course, this is not a confirmed purchase order or a guaranteed 2026 shipment target. There's also no guarantee that the NTN products will carry the same ASP. However, if the current delays are primarily related to the customer's commercialization timeline rather than lost demand, I believe meaningful shipment volumes could materialize over the next year or two. The broader satellite industry is also making encouraging progress. This year, AST SpaceMobile received conditional FCC approval for its 248-satellite constellation and satellite-to-phone services. Meanwhile, SpaceX's 14th Starship flight successfully reached orbit and deployed satellites. These developments suggest that some of the industry's regulatory, spectrum, and launch-capacity constraints may gradually ease. That doesn't mean all the bottlenecks have disappeared. More delays are certainly possible. But the overall direction still seems to be toward commercialization. I also view the recent Kratos 5G NR NTN demonstration involving GCTS's chipset as a positive technical milestone. If it represents a business opportunity separate from the unnamed satellite customer, even better. **The satellite communications industry appears to be moving toward broader commercialization despite repeated delays. The real question is how much of that growth GCTS can actually capture.** # 3. Technical Validation Is Progressing — Commercialization and Monetization Remain Unproven This is probably the most important part of my investment thesis. In my view, GCTS has done a good job validating its technology and building customer references across FWA, aviation communications, NTN, and UAV applications. However, **large-scale commercialization and sustainable monetization have yet to be demonstrated.** 5G chip shipments increased from over 1,900 units in Q4 2025 to more than 5,100 units in Q2 2026, but product revenue remains relatively small. Another encouraging development was the approximately $15.47 million semiconductor manufacturing supply agreement with AlphaChips announced in April. I see this as a positive indication of production preparations, although manufacturing commitments and actual customer sales are two different things. Ultimately, investors can only assess GCTS's commercialization and monetization prospects indirectly through technical milestones, customer references, and developments in the FWA and NTN markets. And honestly, that's one of the most frustrating aspects of holding this stock. Management doesn't provide much visibility into customer-level product revenue or detailed production timelines between earnings calls. For now, I'm watching quarterly shipment volumes, product revenue, and gross margins, hoping to see all three improve together. # 4. TAM Expansion and Risks I also view the recently announced UAV-related agreement positively. Looking further ahead, I see potential opportunities in robotics, smart glasses, industrial IoT, and other AI-powered edge devices. It would be great to see GCTS benefit from AI data center demand the way MaxLinear has, with new business opportunities eventually translating into actual revenue. But realistically, expanding into new categories of connected edge devices may be a more natural opportunity for GCTS. For now, though, I treat these markets as optional upside rather than something already supported by meaningful commercial traction. On the risk side, my biggest concern is SpaceX's overwhelming vertical integration and Starlink's competitive position. Even if the overall satellite communications market grows rapidly, GCTS's unnamed satellite partner could end up capturing a smaller share of the market than expected. Customer launch delays and further shareholder dilution are also significant risks. I've also noticed periods when GCTS stock has moved somewhat in line with ASTS, Rocket Lab, and MaxLinear, and to a lesser extent Inseego. That's just my personal observation, not a statistical correlation study. I suspect some of GCTS's valuation is influenced by the market's enthusiasm for NTN and satellite-related stocks. But **in the long run, I believe sustainable share price appreciation will have to be supported by increasing chip shipments, product revenue, and ultimately profitability.** # Final Thoughts Watching the stock fall from $4 to $1.70 has certainly been frustrating. Still, I don't believe the core reasons behind my investment — GCTS's technological potential and the long-term growth of its target markets — have fundamentally deteriorated. That said, the delays in revenue growth and the shareholder dilution are real negatives that shouldn't be ignored. **To me, GCTS is a company that has made meaningful progress in technical validation and building industry references, but now needs to prove that those achievements can translate into commercialization and sustainable monetization.** The possibility that GCTS chips could find their way into new types of connected devices, sometimes in markets we haven't even anticipated yet, is still an exciting part of the investment. But at this point, I'd really like to see the numbers start catching up with the potential. I'd be interested to hear what other long-term shareholders think, particularly regarding the unnamed satellite customer's commercialization timeline and the outlook for FWA-related chip shipments. What are you watching most closely?